Fundraising FoxIqirvo
1 known investors
Find your way into Iqirvo
Sign up to see every warm intro you have to Iqirvo
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Iqirvo team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
IQIRVO is a prescription medicine for treating primary biliary cholangitis (PBC) in adults, used either in combination with ursodeoxycholic acid or as a standalone treatment for patients unable to tolerate standard therapy.
Investors · 1
Frequently asked questions
- What does Iqirvo do?
- IQIRVO is a prescription medicine for treating primary biliary cholangitis (PBC) in adults, used either in combination with ursodeoxycholic acid or as a standalone treatment for patients unable to tolerate standard therapy.
- Who are Iqirvo's investors?
- Iqirvo's investors include HEALTHCARE ROYALTY PARTNERS.